ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage‐Mediated Metastatic Colonization
Advanced Science · 2025
DOI: 10.1002/advs.202505291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiangjun Qian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 7 Weiwu Road, zhe…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Macrophages, Argininosuccinate Synthase, Urea. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Project, Henan Provincial Science and Technology Research Plan Provincial and Ministerial Youth Project.
Abstract (Originalsprache)
Colorectal cancer (CRC) progression is driven by diverse molecular mechanisms, underscoring the urgent need for novel therapeutic strategies, especially for liver metastases. Through an integrated analysis of multiple single‐cell RNA sequencing databases, zinc finger protein‐like 1 (ZFPL1) is identified as a gene specifically enriched in malignant cells from both primary and metastatic CRC. Multi‐omics investigations demonstrate that high ZFPL1 expression correlates with aggressive clinicopathological features and poor survival. Functionally, ZFPL1 promotes tumor proliferation, invasion, and migration both in vivo and in vitro. Mechanistically, ZFPL1 directly binds argininosuccinate synthase 1 (ASS1), shielding its K57 residue from tripartite motif containing 33‐mediated ubiquitination to prevent proteasomal degradation. This stabilization activates urea cycle metabolism, driving CRC progression. Crucially, ZFPL1 deficiency remodels the tumor microenvironment by reducing immunosuppressive populations‐M2 macrophages, and promoting pro‐inflammatory M1 polarization. Virtual screening identifies Salvianolic acid B (Sal B) as a ZFPL1 inhibitor, which disrupts ZFPL1‐ASS1 binding, triggering ASS1 ubiquitination and degradation. In vivo, Sal B synergized with anti‐PD‐1 therapy, significantly reducing tumor burden versus monotherapy. These findings establish ZFPL1 as a key regulator of CRC progression through ASS1‐dependent urea cycle activation and immunomodulation, nominating the ZFPL1‐ASS1 axis as a therapeutic target, with Sal B demonstrating combinatorial potential with immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 7 Weiwu Road, zhengzhou, 450000, China.
- Department of Hepatobiliary and Pancreatic Surgery, People's Hospital of Zhengzhou University, Zhengzhou, China.
- Hepatobiliary Center, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Hepatobiliary cancers, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Chin…
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
ORCID-Profile: Weiwei Tang, Xiaopei Hao
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Project
- Henan Provincial Science and Technology Research Plan Provincial and Ministerial Youth Project
- National Key Clinical Discipline Construction Project
Zitieren
APA
Qian, X., Xie, C., Zhang, B., Cao, H., Lu, Z., Liu, L., Dai, S., Wang, X., Zhang, X., Han, F., Liu, Y., Yu, H., Tang, W., Zhou, J., & Hao, X. (2025). ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage‐Mediated Metastatic Colonization. Advanced Science. https://doi.org/10.1002/advs.202505291
Vancouver
Qian X, Xie C, Zhang B, Cao H, Lu Z, Liu L, et al. ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage‐Mediated Metastatic Colonization. Advanced Science. 2025. doi:10.1002/advs.202505291
BibTeX
@article{Qian2025,
author = {Qian, Xiangjun and Xie, Chenxi and Zhang, Beilin and Cao, Hengsong and Lu, Zhengqing and Liu, Li and Dai, Shipeng and Wang, Xiaoqian and Zhang, Xiaokai and Han, Feng and Liu, Yanyan and Yu, Haibo and Tang, Weiwei and Zhou, Jinxue and Hao, Xiaopei},
title = {ZFPL1 Promotes Colorectal Cancer Progression by Stabilizing ASS1 to Drive the Urea Cycle and M2 Macrophage‐Mediated Metastatic Colonization},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202505291}
}
EUVIMED